Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis
- PMID: 6816332
- PMCID: PMC1500707
- DOI: 10.1136/bmj.285.6356.1688
Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis
Abstract
The effects of prostaglandin E1 infusion on nailfold capillary haemodynamics were studied in eight patients with Raynaud's phenomenon secondary to progressive systemic sclerosis. Using a modified Landis microinjection technique the mean (+/- SEM) transcapillary pressure gradient was increased during and six weeks after infusion by 13.9 +/- 3.2 cm H2O (p less than 0.05) and 5.5 +/- 2.5 cm H2O (p less than 0.05) respectively. Capillary red cell velocity measured in two patients by video television microscopy also increased during and after infusion with prostaglandin E1. Six patients claimed subjective benefit and in three their ulcers healed. These findings support the observed beneficial effect of prostaglandin E1 and suggest that it improves the nutritive capillary circulation by lowering precapillary resistance.
Similar articles
-
Hemodynamics in nailfold capillaries of patients with systemic scleroderma: synchronous measurements of capillary blood pressure and red blood cell velocity.J Invest Dermatol. 1998 Jun;110(6):982-5. doi: 10.1046/j.1523-1747.1998.00190.x. J Invest Dermatol. 1998. PMID: 9620310
-
The effect of local temperature versus sympathetic tone on digital perfusion in Raynaud's phenomenon.Angiology. 1990 Sep;41(9 Pt 1):715-23. doi: 10.1177/000331979004100906. Angiology. 1990. PMID: 2221472 Clinical Trial.
-
Treatment of vasospastic disease with prostaglandin E1.Br Med J. 1980 Oct 18;281(6247):1031-4. doi: 10.1136/bmj.281.6247.1031. Br Med J. 1980. PMID: 7427564 Free PMC article.
-
[Raynaud's phenomena: diagnostic and treatment study].Rev Prat. 1998 Oct 1;48(15):1659-64. Rev Prat. 1998. PMID: 9814067 Review. French.
-
Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.Arch Dermatol. 1992 May;128(5):630-2. Arch Dermatol. 1992. PMID: 1575525 Review.
Cited by
-
Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment.J Immunol Res. 2021 Jun 24;2021:9920416. doi: 10.1155/2021/9920416. eCollection 2021. J Immunol Res. 2021. PMID: 34258301 Free PMC article. Review.
-
Assessment of platelet function in patients with Raynaud's syndrome.J Clin Pathol. 1984 Feb;37(2):182-7. doi: 10.1136/jcp.37.2.182. J Clin Pathol. 1984. PMID: 6229551 Free PMC article.
-
Remission of secondary Raynaud phenomenon using intra-arterial prostaglandin E1 infusion. A case report.Int Orthop. 1994;18(6):372-4. doi: 10.1007/BF00187085. Int Orthop. 1994. PMID: 7698870
-
Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma.Arch Dermatol Res. 1985;277(4):323-5. doi: 10.1007/BF00509089. Arch Dermatol Res. 1985. PMID: 2408588 No abstract available.
-
The endothelium: its role in scleroderma.Ann Rheum Dis. 1991 Nov;50 Suppl 4(Suppl 4):866-71. doi: 10.1136/ard.50.suppl_4.866. Ann Rheum Dis. 1991. PMID: 1750799 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical